Pharma Exhales, Dodges Financial Blow With Tariff Exemption

 
• By Jessica Merrill

Industry lobbing for pharmaceuticals to be exempt from President Trump’s sweeping US tariffs appears to have paid off.

Tariffs still could be added to pharmaceuticals later, analysts cautioned. (Shutterstock)

More from Manufacturing

More from Compliance